Aug 11, 2026 04:06PM
Aug 11, 2026 04:05PM
Aug 5, 2026 04:05PM
Jun 18, 2026 08:00AM
Jun 16, 2026 08:02AM
Jun 16, 2026 08:00AM
Jun 1, 2026 11:00AM Innoviva to Participate in Upcoming Investor Conferences
May 6, 2026 04:05PM
Feb 25, 2026 04:05PM
Feb 19, 2026 08:00AM
Dec 16, 2025 06:53AM
Dec 12, 2025 04:56PM
Dec 12, 2025 04:56PM
Dec 11, 2025 06:35PM Innoviva announces Lancet publication of gonorrhea drug trial results
Dec 11, 2025 06:35PM
Nov 5, 2025 04:05PM
Oct 20, 2025 08:01AM
Oct 20, 2025 08:00AM
Oct 7, 2025 08:00AM
Aug 13, 2025 08:00AM
Aug 6, 2025 04:05PM Innoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress
Jun 12, 2025 07:00AM
Jun 12, 2025 07:00AM
Jun 10, 2025 06:01AM
Jun 10, 2025 06:00AM
May 20, 2025 06:00AM
May 20, 2025 01:15AM
May 7, 2025 04:05PM Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress
Mar 12, 2025 05:09PM
Mar 12, 2025 05:08PM
Feb 26, 2025 04:04PM
Dec 16, 2024 07:01AM
Dec 16, 2024 07:00AM
Nov 6, 2024 04:05PM
Jul 31, 2024 04:05PM Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
May 8, 2024 04:05PM
Feb 29, 2024 04:05PM
Oct 11, 2023 08:00AM
Sep 18, 2023 08:00AM
Aug 2, 2023 04:05PM
May 24, 2023 05:41AM
May 23, 2023 06:42PM Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO® (sulbactam for injection; durlobactam for injection), Co-packaged for Intravenous Use
May 12, 2023 05:41AM
May 11, 2023 06:45PM
May 9, 2023 04:32PM
Apr 17, 2023 04:32PM
Apr 17, 2023 04:31PM
Apr 17, 2023 09:01AM
Apr 17, 2023 09:00AM Innoviva Stock Trading Halted Today
Apr 17, 2023 08:57AM

329,987 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All